Athersys, Inc.

3201 Carnegie Avenue
44115-2634 Cleveland
USA

About Athersys

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life.

Product portfolio of Athersys

Product portfolio

Show all

Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing

Advanced CHO Cell Line Development Technology for In-House Implementation

High-Recovery Anion Exchange Membrane Chromatography for Lentiviral Vector Purification

News about Athersys

03-Feb-2012 | business & finance

Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development

Funding supports advancement for treatment of neurological and cardiovascular conditions & advanced manufacturing platform

Read news

27-Sep-2010 | research and development

Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell ...

Read news

Show more news about Athersys

Holistic Multi-Column Chromatography Solution

Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing

Maximum binding capacity in ion exchange chromatography

Here you will find Athersys, Inc.

Last viewed contents

Escitalopram

Go to page